120 related articles for article (PubMed ID: 8589358)
1. Recombinant human erythropoietin (rhEPO) administration to marrow donors. Bone Marrow Transplantation (BMT) Team.
Akiyama H; Tanikawa S; Takamoto S; Sakamaki H; Sasaki T; Onozawa Y
Int J Hematol; 1995 Oct; 62(3):145-9. PubMed ID: 8589358
[TBL] [Abstract][Full Text] [Related]
2. Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Baron F; Sautois B; Baudoux E; Matus G; Fillet G; Beguin Y
Exp Hematol; 2002 Jun; 30(6):546-54. PubMed ID: 12063021
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients.
Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Lombardini L; Rossi-Ferrini P
Leukemia; 1992 Mar; 6(3):215-9. PubMed ID: 1564959
[TBL] [Abstract][Full Text] [Related]
4. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
[TBL] [Abstract][Full Text] [Related]
5. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
[TBL] [Abstract][Full Text] [Related]
6. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin.
Biesma DH; Marx JJ; Kraaijenhagen RJ; Franke W; Messinger D; van de Wiel A
Lancet; 1994 Aug; 344(8919):367-70. PubMed ID: 7914307
[TBL] [Abstract][Full Text] [Related]
7. [The perioperative use of recombinant erythropoietin (rhEPO) in Jehovah's witnesses].
Soukup J; Menzel M; Roth S; Radke J
Anaesthesist; 1996 Aug; 45(8):745-9. PubMed ID: 8967587
[TBL] [Abstract][Full Text] [Related]
8. Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation.
Locatelli F; Zecca M; Ponchio L; Beguin Y; Giorgiani G; Maccario R; Bonetti F; De Stefano P; Cazzola M
Bone Marrow Transplant; 1994 Dec; 14(6):929-35. PubMed ID: 7536073
[TBL] [Abstract][Full Text] [Related]
9. The use of erythropoietin in the treatment of post-bone marrow transplantation anemia.
Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Bacci P; Lombardini L; Rossi-Ferrini P
Int J Artif Organs; 1993 Dec; 16 Suppl 5():8-12. PubMed ID: 8014003
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study.
Beris P; Mermillod B; Levy G; Laubriat M; Soulier-Lauper M; Tullen E; Hugli A; Miescher PA
Vox Sang; 1993; 65(3):212-8. PubMed ID: 8249364
[TBL] [Abstract][Full Text] [Related]
11. Finding the optimal regimen for short-term daily recombinant human erythropoietin treatment for blood-saving purpose in patients undergoing unilateral primary total hip arthroplasty: a double-blinded randomized placebo-controlled trial.
Yuan M; Tao Q; Wang D; Wang H; Zhou Z
BMC Musculoskelet Disord; 2022 Mar; 23(1):243. PubMed ID: 35279105
[TBL] [Abstract][Full Text] [Related]
12. Antierythropoietin antibodies in thalassemia patients.
Voulgari PV; Chaidos A; Tzouvara E; Alymara V; Alamanos Y; Drosos AA; Bourantas KL
Ann Hematol; 2004 Jan; 83(1):22-7. PubMed ID: 14530877
[TBL] [Abstract][Full Text] [Related]
13. Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.
Mitus AJ; Antin JH; Rutherford CJ; McGarigle CJ; Goldberg MA
Blood; 1994 Apr; 83(7):1952-7. PubMed ID: 8142661
[TBL] [Abstract][Full Text] [Related]
14. Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes.
Stone RM; Bernstein SH; Demetri G; Facklam DP; Arthur K; Andersen J; Aster JC; Kufe D
Leuk Res; 1994 Oct; 18(10):769-76. PubMed ID: 7934135
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation.
Fujimori Y; Kanamaru A; Saheki K; Mori A; Takatsuka H; Wada H; Okada M; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K
Int J Hematol; 1998 Feb; 67(2):131-6. PubMed ID: 9631579
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin in autologous blood donors: a dose-finding study.
Biesma DH; Kraaijenhagen RJ; Dalmulder J; Marx JJ; Van De Wiel A
Br J Haematol; 1994 Jan; 86(1):30-5. PubMed ID: 8011544
[TBL] [Abstract][Full Text] [Related]
17. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
18. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO).
Rau B; Schlag PM; Willeke F; Herfarth C; Stephan P; Franke W
Eur J Cancer; 1998 Jun; 34(7):992-8. PubMed ID: 9849445
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
[TBL] [Abstract][Full Text] [Related]
20. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
Vannucchi AM; Bosi A; Lombardini L; Grossi A; Bacci P; Guidi S; Saccardi R; Rossi-Ferrini P
Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
